Aditx Therapeutics Files DEF 14A on Apr 8, 2026 Aditx Therapeutics filed a Form DEF 14A on 8 Apr 2026 (Investing.com); institutional holders should review director nominations and compensation tables ahead of the shareholder meeting.

Aditx Therapeutics Files DEF 14A on Apr 8, 2026: Aditx Therapeutics filed a Form DEF 14A on 8 Apr 2026 (Investing.com); institutional holders should review director nominations and compensation… 👈 Read full analysis #AditxTherapeutics #DEF14A #Investing #ShareholderMeeting #CorporateGovernance